Partners Venture Sofinnova VII Net Worth & Insider Trades
Partners Venture Sofinnova VII Aerie Pharmaceuticals Inc
What is Partners Venture Sofinnova VII's Net Worth?
The current estimated net worth of Aerie Pharmaceuticals Inc's Partners Venture Sofinnova VII is estimated to be about $70.2M . Partners Venture Sofinnova VII owns about 0 unit of Aerie Pharmaceuticals Inc common stock. In the last year at Aerie Pharmaceuticals Inc, Partners Venture Sofinnova VII has sold an estimated value of $29.39M worth.
What is Partners Venture Sofinnova VII's Past Insider Trading?
Partners Venture Sofinnova VII's largest purchase order was 3,090,589 units , worth over $2.86M on October 30, 2013. Partners Venture Sofinnova VII's largest sale order was 1,008,022 units , worth over $24.21M on July 11, 2014. In total, Partners Venture Sofinnova VII has made about 4 transactions over a year of their time at Aerie Pharmaceuticals Inc. Partners Venture Sofinnova VII usually trades in June, October, May and July, with the busiest year in 2014.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PARTNERS VENTURE SOFINNOVA VII, Sofinnova Management VII LLC, JAMES HEALY, Eric Buatois, MICHAEL POWELL
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Partners Venture Sofinnova VII's' Mailing Address?
- Mailing address is 3000 Sand Hill Road, 4-250road Menlo Park CA 94025 CA
What are Aerie Pharmaceuticals Inc's Past Insider Trades?
Aerie Pharmaceuticals Inc's most recent insider trade came on November 12, 2020 by Casey C Kopczynski who sold 30,000 units worth $390.17K . In the last 7 years, insiders at Aerie Pharmaceuticals Inc have sold an estimated value of $236.4M and bought an estimated value of $40.78M worth of shares. Insider trading is most common in February, with the busiest year in 2019. The most active traders at the company are Casey C Kopczynski, Chief Scientific Officer, Richard J Rubino, Chief Financial Officer, and Thomas A Mitro, President and COO .
AERIE PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |